SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Pastrami on Rye

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: epicure who wrote (52)3/11/2008 2:59:29 AM
From: Mike McFarland  Read Replies (2) of 379
 
<I want Curis to go to a buck>

cris was off 20% on Monday, to $1.15. After trading through
the fall around a buck a share it rose to a buck and a half
and now looks poised to go back to a buck.

Gene Logic is well below that one dollar target, halved
since then, the new symbol is ORXE and it has traded down
to 50 cents a share on Monday. I've not been averaging
down on my position--which is trivial at this price.
I once sold a microcap biotech at 50 cents a share, half
my position in fact, then watched it go up to $4, where
I sold out, then watched it go to $40. But that was then
and this is now--I am not optimistic now.

ANDS has also been halved since I mentioned it.
INFI is around $7, but it may yet fall to $5,
who can say.

fwiw, I'm 99% cash. I think there are better stocks to
own than this bunch that I have followed, microcap
biotechs that trade below book have not done well for me.
A couple dozen biotechs trade below cash now, but they might
not be worth buying just coz they're cheap (no kidding, heh).
Other biotechs may be worth a look.

I may buy a mutual fund this spring, maybe a growth or
tech fund. I've considered RYJUX from time to time,
it may be worth a look soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext